Chico's, Inc. (CHS) PT Lowered to $10 at UBS; Reiterates Neutral

Go back to Chico's, Inc. (CHS) PT Lowered to $10 at UBS; Reiterates Neutral

Chico's, Inc. (CHS) PT Lowered to $11 at Deutsche Bank Following 1Q

May 25, 2017 9:19 AM EDT

Deutsche Bank lowered its price target on Chico's, Inc. (NYSE: CHS) to $11.00 (from $16.00) while maintaining a Hold rating.... More

Chico's, Inc. (CHS) PT Lowered to $11 at Jefferies

May 25, 2017 9:10 AM EDT

Jefferies lowered its price target on Chico's, Inc. (NYSE: CHS) to $11.00 (from $14.00) while maintaining a Hold rating.

... More

Chico's, Inc. (CHS) PT Lowered to $13 at Citi

May 25, 2017 8:40 AM EDT

Citi lowered its price target on Chico's, Inc. (NYSE: CHS) to $13.00 (from $18.00) while maintaining a Buy rating.

... More

Chico's, Inc. (CHS) PO Lowered to $12 at BofA/Merrill Lynch; '1Q EPS Misses as Weak Comps Offset Margin Leverage'

May 25, 2017 6:59 AM EDT

BofA/Merrill Lynch lowered its price objective on Chico's, Inc. (NYSE: CHS) to $12.00 (from $16.50) while maintaining a Neutral rating, following the company's first quarter earnings report.

Analyst Lorraine Hutchinson notes the company delivered first quarter earnings per share and revenue results below the... More

Chico's, Inc. (CHS) PT Lowered to $11 at Jefferies

May 25, 2017 6:54 AM EDT

Jefferies lowered its price target on Chico's, Inc. (NYSE: CHS) to $11.00 (from $14.00) while maintaining a Hold rating.

Analyst Randal Konik likes the strategy of the company given the focus on driving more profitable sales and cost/inventory discipline but he cautions clients Thursday morning that the environment remains tough.

... More

Pre-Open Stock Movers 05/24: (INO) (TCS) (TLYS) Higher; (ANW) (DY) (CHS) Lower (more...)

May 24, 2017 9:27 AM EDT

Today's Pre-Open Movers

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) 41.8% HIGHER; announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated in a human study by an HIV vaccine. The vaccine candidate, PENNVAX-GP, consists of a... More

Chicos FAS (CHS) Misses Q1 EPS by 3c, Comps Fall 8.7%

May 24, 2017 7:32 AM EDT

Chicos FAS (NYSE: CHS) reported Q1 EPS of $0.26, $0.03 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $583.7 million versus the consensus estimate of $624.75 million.

This revenue decrease of 9.2% primarily reflects a decline in comparable sales of 8.7%,... More

Chicos (CHS) call put ratio 18 calls to 1 put into Q1 EPS

May 23, 2017 10:54 AM EDT

Chicos FAS (NYSE: CHS) June 10 and 12 puts are active on total put volume of 1,8400 contracts ( 103 puts) into the expected release of Q1 results on May 24. June call option implied volatility is at 55, July is at 45; compared to its 52-week range of 35 to 61.

... More